Cypherpunk Technologies Inc.
NCM: CYPHLive Quote
📈 ZcoreAI Score
Our AI model analyzes Cypherpunk Technologies Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get CYPH Z-Score →About Cypherpunk Technologies Inc.
Financial Services
Asset Management
Cypherpunk Technologies Inc., a privacy technology company, implements a digital asset strategy anchored by Zcash in the United States. The company is involved in identifying, developing, investing in, acquiring, and building privacy-enhancing technologies; and accumulating digital assets, such as ZCash. It also develops biomarker-targeted antibody therapies for patients with cancer and other diseases comprising DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which has completed Phase 2 study for the treatment of colorectal cancer; and FL-501, a monoclonal antibody inhibiting the GDF-15 protein, which is in preclinical development to treat cancer cachexia, hyperemesis gravidarum and pregnancy-related nausea and vomiting, and other diseases associated with aging and frailty. The company was formerly known as Leap Therapeutics, Inc. and changed its name to Cypherpunk Technologies Inc. in November 2025. Cypherpunk Technologies Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.
📊 Fundamental Analysis
Cypherpunk Technologies Inc. demonstrates a profit margin of 0.0%, which is below the sector average, suggesting competitive pressure.
Return on Equity (ROE) is 5.1%, which suggests room for improvement in capital utilization.
At a current price of $1.06, CYPH currently sits at the 24th percentile of its 52-week range (Range: $0.23 - $3.70).
💰 Valuation Insight
CYPH is valued broadly in line with the sector at a PE of 15.14.
🏥 Financial Health
🔴
Profit Margin
Weak
✅
Debt/Equity
Excellent
🔴
Return on Equity
Weak
✅
Beta (Risk)
Low Volatility
Key Financials
Market Cap
$95.38M
Trailing P/E
15.14
Forward P/E
--
Beta (5Y)
-0.22
52W High
$3.70
52W Low
$0.23
Avg Volume
2.49M
Day High
Day Low